Back to search

Article

De novo Identification of Potent ingredients for Proteasome Activation in MT101-5 using an AI-Driven Approach

2025-02-26

Abstract excerpt

Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the intracellular accumulation of α-synuclein (α-syn) protein within Lewy bodies, which are hallmark neuropathological lesions of α-synucleinopathies. Network analysis, incorporating prior knowledge such as biological pathways and gene expression data from patients with PD, was used to identify the pharmaceutically active ingredients of MT10...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
686e448a-3efc-53d5-a6ee-fd6638655875
DOI
10.22541/au.174060381.18927227/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
De novo Identification of Potent ingredients for Proteasome Activation in MT101-5 using an AI-Driven ApproachDOI 10.22541/au.174060381.18927227/v1
Polypharmacological drug design opportunities against Parkinson's diseaseSemantic proximity
Exploring bioactive natural products for treating neurodegenerative diseases: a computational network medicine approach targeting the estrogen signaling pathway in amyotrophic lateral sclerosis and Parkinson’s diseaseSemantic proximity
On Additive Artificial Intelligence Discovery of Nanoparticle-Neurodegenerative Disease Drug Delivery SystemsSemantic proximity
Artificial intelligence for drug discovery and development in Alzheimer's diseaseSemantic proximity
Artificial intelligence-augmented drug discovery identifies gefitinib as a potential treatment for ALSSemantic proximity
Screening novel drug candidates for Alzheimer’s disease by an integrated network and transcriptome analysisSemantic proximity
Quantitative and Systems Pharmacology 3. Network-Based Identification of New Targets for Natural Products Enables Potential Uses in Aging-Associated DisordersSemantic proximity
Inhibition of α-synuclein aggregation by MT101-5 is neuroprotective in mouse models of Parkinson’s diseaseSemantic proximity
Decoding Early Parkinson's: A Network-Based Approach to Drug Target IdentificationSemantic proximity
Exploration of Underlying Mechanisms for Modified Xi-Xin-TangIII in Treating Alzheimer’s Disease through Network Integration InvestigationSemantic proximity
Constructing and characterizing a bioactive small molecule and microRNA association network for Alzheimer's diseaseSemantic proximity
Pathways to healing: Plants with therapeutic potential for neurodegenerative diseasesSemantic proximity
Select a neighboring publication to make it the new centre.